Unigene Laboratories
-
GSK ends $150M licensing deal with Unigene, cue tough questions
Unigene Laboratories is looking for a new partner to commercialize its oral formulation of recombinantly produced […]
Unigene Laboratories is looking for a new partner to commercialize its oral formulation of recombinantly produced […]